
CAS: 1380392-05-1

5-(3-(4-(4-Chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one
CAS:1380392-05-1
Formula:
C25H26ClN3O
Purity:
97%
Color and Shape:
Solid
Molecular weight:
419.9464
Ref: IN-DA01KYPN
5mg | 96.00 € | ||
25mg | 182.00 € | ||
50mg | 321.00 € | ||
100mg | 681.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

5-(3-(4-(4-Chlorophenyl)Piperidin-1-Yl)Propyl)Pyrrolo[1,2-A]Quinoxalin-4(5H)-One
CAS:1380392-05-1
Purity:
97%
Molecular weight:
419.95g/mol
Ref: 54-OR1024227
1g | 1,315.00 € | ||
100mg | 484.00 € | ||
250mg | 808.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

Ref: 54-BUP08794
25mg | 343.00 € | ||
50mg | 515.00 € | ||
100mg | 763.00 € | ||
500mg | 1,391.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025

JMS-17-2
CAS:1380392-05-1
JMS-17-2 is a potent and selective antagonist of CX3CR1( IC50 : 0.32 nM).
Formula:
C25H26ClN3O
Purity:
98.70% - 99.44%
Color and Shape:
Solid
Molecular weight:
419.95
Ref: TM-T5849
1mg | 40.00 € | ||
2mg | 52.00 € | ||
5mg | 87.00 € | ||
10mg | 131.00 € | ||
25mg | 221.00 € | ||
50mg | 344.00 € | ||
100mg | 512.00 € | ||
1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Friday 25 Apr 2025

5-(3-(4-(4-Chlorophenyl)piperidin-1-yl)propyl)pyrrolo[1,2-a]quinoxalin-4(5H)-one
CAS:1380392-05-1
Purity:
97.0%
Molecular weight:
419.95001220703125
Ref: 10-F545292
5mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 28 Apr 2025

JMS-17-2
CAS:1380392-05-1
Versatile small molecule scaffold
Formula:
C25H26ClN3O
Purity:
Min. 95%
Molecular weight:
419.95 g/mol
Ref: 3D-FFC39205
50mg | 6,412.00 € |
Estimated delivery in United States, on Friday 30 May 2025